Ratings by Wolfe Research (Andrew Galler)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/6/2022 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/4/2022 | Moderna | MRNA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/10/2022 | Seagen | SGEN | Maintain | Peerperform (N/A) |
|
Details | ||
| 1/27/2022 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2021 | Moderna | MRNA | New Coverage | Outperform (N/A) |
236.99 (102.29) |
-56.84% | Details | |
| 7/19/2021 | BioNTech | BNTX | New Coverage | Peerperform (N/A) |
231.47 (108.21) |
-53.25% | Details | |
| 7/19/2021 | argenx SE | ARGX | New Coverage | Outperform (N/A) |
309.40 (508.79) |
64.44% | Details | |
| 7/19/2021 | Acceleron Pharma | XLRN | New Coverage | Outperform (N/A) |
117.26 (178.75) |
52.44% | Details | |
| 7/19/2021 | Vertex | VRTX | New Coverage | Outperform (N/A) |
202.28 (353.76) |
74.89% | Details |
